About 198,000 results
Open links in new tab
  1. Generic Drugs: Questions & Answers | FDA

    Generic Drug Facts At-a-glance information on generic medicines, including why they may look different or cost less than brand-name medicines.

  2. Generic Drug Facts | FDA

    Nov 1, 2021 · Generic drugs: Get the facts. Consumer-friendly text and graphics provide a few facts about generic drug approval, quality, and performance.

  3. First Generic Drug Approvals | FDA

    Oct 23, 2025 · FDA considers first generics to be important to public health, and prioritizes review of these submissions.

  4. FDA Roundup: March 4, 2025

    Mar 4, 2025 · On Monday, the FDA approved the first generics of Xarelto (rivaroxaban), 2.5 mg, tablets to reduce the risk of major cardiovascular events in adult patients with coronary artery …

  5. FDA List of Authorized Generic Drugs

    The FDA List of Authorized Generics page answers what an authorized generic is and how it differs from a traditional generic. An authorized generic is used to describe an approved brand …

  6. Fiscal Year 2025 Generic Drug Science and Research Initiatives …

    May 22, 2025 · Topics discussed during the workshop will focus on research that is needed to address scientific knowledge gaps and associated challenges impacting the development and …

  7. This list of authorized generic drugs (AGs) was created from a manual review of FDA’s database of annual reports submitted to the FDA since January 1, 1999 by sponsors of new drug …

  8. Office of Generic Drugs 2023 Annual Report | FDA

    Mar 4, 2024 · Our 2023 Annual Report provides highlights of activities and accomplishments including generic drug approvals, first generic approvals, science and research innovations for …

  9. Generics (typically small molecules) and biosimilars (typically larger, more complex molecules) are approved through different abbreviated pathways that avoid duplicating certain costly …

  10. Biosimilars Basics for Patients | FDA

    Biosimilars and generics are both versions of previously FDA approved medications and may offer more affordable treatment options to patients.